Evidence map›Paper›PMID 24280956›Full record

Trial reportKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2015

Healing of donor site in bone-tendon-bone ACL reconstruction accelerated with plasma rich in growth factors: a randomized clinical trial.

Roberto Seijas, Marta Rius, Oscar Ares, Montserrat García-Balletbó, Iván Serra, Ramón Cugat

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. ACL Reconstruction with Augmentation: a Scoping Review.Current reviews in musculoskeletal medicine · 2019
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Roberto SeijasOrthopaedic Surgery, Artroscopia G.C., Fundación García-Cugat, Hospital Quirón Barcelona, Pza. Alfonso Comín 5-7, 08023, Barcelona, Spain, roberto6jas@gmail.com.
Marta Rius
Oscar Ares
Montserrat García-Balletbó
Iván Serra
Ramón Cugat
Hospital Quirónsalud Barcelona · ESUniversidad Cardenal Herrera CEU · ESUniversitat Internacional de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo determine whether the use of plasma rich in growth factors accelerates healing of the donor site in bone-tendon-bone anterior cruciate ligament (ACL) reconstruction (patellar graft). The use of the patellar graft presents post-operative problems such as anterior knee pain, which limits its use and leads to preference being taken for alternative grafts.

methodsA double-blind, randomized, clinical trial was performed comparing two groups of patients who underwent ACL reconstruction using patellar tendon graft and comparing the use of plasma rich in growth factors at the donor site after graft harvest in terms of local regeneration by ultrasound assessment.

resultsThe plasma rich in growth factors group shows earlier donor site regeneration in comparison with the control group (2 months earlier), with significant differences in the first 4 months of the follow-up.

conclusionThe application of plasma rich in growth factors shows accelerated tissue regeneration processes with respect to the control group. This fact, together with the previously published with similar conclusions, can create a knowledge basis in order to set out new recovery guidelines following ACL reconstruction. LEVEL OF EVIDENCE: Therapeutic study, Level I.

Indexed as

Anterior Cruciate Ligament InjuriesPlasmaWound HealingAdolescentAdultAgedAnterior Cruciate Ligament ReconstructionDouble-Blind MethodFemaleFollow-Up StudiesHumansIntercellular Signaling Peptides and ProteinsKnee InjuriesLiving DonorsMaleMiddle AgedIntercellular Signaling Peptides and Proteins

Identifiers

PMID24280956
OpenAlexW2061960061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.